Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic pancreatitis (CP) and cystic fibrosis
3.2.1.2 Growing aging population
3.2.1.3 Advancements in diagnosis
3.2.1.4 Technological advancements in pharmaceutical industry
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Limited awareness and education
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Treatment, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Nutritional management
5.3 Pancreatic enzyme replacement therapy (PERT)
Chapter 6 Market Estimates and Forecast, By Drug Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Creon
6.3 Zenpep
6.4 Pancreaze
6.5 Viokace
6.6 Other drug types
Chapter 7 Market Estimates and Forecast, By Symptom, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Abdominal pain
7.3 Constipation
7.4 Diarrhea
7.5 Fatty stools
7.6 Weight loss
7.7 Other symptoms
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 AbbVie
10.3 Digestive Care
10.4 Essential Pharma
10.5 Nestle
10.6 Nordmark Pharma
10.7 Sun Pharmaceutical Industries
10.8 Viatris
10.9 Vivus
10.10 Zentiva Pharma UK
